Literature DB >> 2411789

Calcium ionophore plus phorbol ester can substitute for antigen in the induction of cytolytic T lymphocytes from specifically primed precursors.

A Truneh, F Albert, P Golstein, A M Schmitt-Verhulst.   

Abstract

Previous studies indicated that Ca++ ionophores and phorbol esters in synergy could substitute for the initial activation step of normal T lymphocytes or T cell clones leading to increased expression of receptors for the growth factor interleukin 2 (IL 2) and secretion of interleukins, with the mitogenic signal for T cell proliferation being dependent on the presence of IL 2. In this study, the question was addressed as to whether T lymphocytes activated through the Ca++ ionophore ionomycin and the phorbol ester 12-o-tetradecanoyl phorbol 3-acetate (TPA) also acquired the competence to kill relevant target cells. The results indicate that T lymphocytes from primed mice proliferate and lyse the relevant allogeneic target cells after in vitro stimulation with ionomycin plus TPA, and that T lymphocyte preparations enriched for a subpopulation bearing the Lyt-2 marker are dependent on exogeneous sources of IL 2 to proliferate and become competent killer cells, whereas preparations enriched for subpopulations bearing the L3T4 marker grow independently of exogenous IL 2.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411789

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  E-selectin ligands as mechanosensitive receptors on neutrophils in health and disease.

Authors:  S D Chase; J L Magnani; S I Simon
Journal:  Ann Biomed Eng       Date:  2012-01-24       Impact factor: 3.934

2.  Spleen lymphocyte function modulated by a cocoa-enriched diet.

Authors:  E Ramiro-Puig; F J Pérez-Cano; C Ramírez-Santana; C Castellote; M Izquierdo-Pulido; J Permanyer; A Franch; M Castell
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

Review 3.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

Review 4.  Calcium signalling and related ion channels in neutrophil recruitment and function.

Authors:  Roland Immler; Scott I Simon; Markus Sperandio
Journal:  Eur J Clin Invest       Date:  2018-06-22       Impact factor: 4.686

5.  Alloantigen-induced unresponsiveness in cord blood T lymphocytes is associated with defective activation of Ras.

Authors:  P Porcu; J Gaddy; H E Broxmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

6.  Elimination of IgE regulatory rat CD8+ T cells in vivo differentially modulates interleukin-4 and interferon-gamma but not interleukin-2 production by splenic T cells.

Authors:  D Diaz-Sanchez; A Noble; D Z Staynov; T H Lee; D M Kemeny
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

7.  Calcium flux in neutrophils synchronizes beta2 integrin adhesive and signaling events that guide inflammatory recruitment.

Authors:  Ulrich Y Schaff; Itsukyo Yamayoshi; Tiffany Tse; Donald Griffin; Lilian Kibathi; Scott I Simon
Journal:  Ann Biomed Eng       Date:  2008-02-16       Impact factor: 3.934

8.  T helper 1 (Th1)/Th2 cytokine expression shift of peripheral blood CD4+ and CD8+ T cells in patients at the post-acute phase of stroke.

Authors:  G L Theodorou; S Marousi; J Ellul; A Mougiou; E Theodori; A Mouzaki; M Karakantza
Journal:  Clin Exp Immunol       Date:  2008-04-16       Impact factor: 4.330

9.  In vitro modulation of leucocyte-function-associated antigen-1 expression on two leukemic cell lines.

Authors:  A Altmeyer; C Moog; C Waltzinger; G Hauptmann; P Bischoff
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

10.  Induction of T-cell receptor-alpha and -beta mRNA in SL12 cells can occur by transcriptional and post-transcriptional mechanisms.

Authors:  M F Wilkinson; C L MacLeod
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.